Viracta Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Viracta Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2011 to Q3 2024.
  • Viracta Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 39.6M shares, a 2.3% increase year-over-year.
  • Viracta Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 38.6M shares, a 2.21% increase from 2022.
  • Viracta Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 37.8M shares, a 18.6% increase from 2021.
  • Viracta Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 31.9M shares.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 39.6M +890K +2.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 39.4M +845K +2.19% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 39.3M +865K +2.25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 38.6M +833K +2.21% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 38.7M +978K +2.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 38.6M +961K +2.56% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 38.5M +923K +2.46% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 37.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 37.7M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 37.6M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 37.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2017 31.7M +12.4M +64.2% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-09
Q3 2017 23.7M +9.18M +63.3% Jul 1, 2017 Sep 30, 2017 10-K 2018-03-09
Q2 2017 21.5M +7.03M +48.5% Apr 1, 2017 Jun 30, 2017 10-K 2018-03-09
Q1 2017 21M +6.59M +45.6% Jan 1, 2017 Mar 31, 2017 10-K 2018-03-09
Q4 2016 19.3M +6.5M +50.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 14.5M +2.04M +16.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-09
Q2 2016 14.5M +2.41M +19.9% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-09
Q1 2016 14.4M +3.17M +28.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-09
Q4 2015 12.8M -50.3M -79.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-09
Q3 2015 12.5M -48.1M -79.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-09
Q2 2015 12.1M -49.8M -80.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-09
Q1 2015 11.3M -45M -80% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-09
Q4 2014 63M +7.47M +13.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 60.5M +7.28M +13.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 61.9M +8.63M +16.2% Mar 31, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 56.3M +4.73M +9.16% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 55.6M +2.73M +5.16% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 53.3M +5.87M +12.4% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 53.3M +5.98M +12.7% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 51.6M +4.79M +10.2% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 52.8M +6.12M +13.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 47.4M +684K +1.46% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-06
Q2 2012 47.3M +991K +2.14% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-06
Q1 2012 46.8M -1.07M -2.24% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-06
Q4 2011 46.7M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-13
Q3 2011 46.7M Jul 1, 2011 Sep 30, 2011 10-K 2013-03-13
Q2 2011 46.3M Apr 1, 2011 Jun 30, 2011 10-K 2013-03-13
Q1 2011 47.9M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.